ArticlePloS one2020

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial.

Adam Kurkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.